To further explore the relationship between RNF26 and CBX7 in renal cancer cells, we treated renal cancer cells with or without a 26S proteasome inhibitor (MG132) under conditions of knockdown or overexpression of RNF26 (Fig. 6A, B). This evidence concerns the gene RNF26 and renal carcinoma.